共 186 条
- [11] Leisenring W(2016)Prevalence and risk factors of early endocrine disorders in childhood brain tumor survivors: a nationwide, multicenter study J Clin Oncol 34 4362-4370
- [12] Hudson MM(2016)Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma Neuro Oncol 18 881-887
- [13] Donaldson SS(2005)Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63 362-372
- [14] King AA(1997)Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation Int J Radiat Oncol Biol Phys 38 805-811
- [15] Stovall M(2004)Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma Int J Radiat Oncol Biol Phys 58 727-734
- [16] Krull KR(2018)Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma Pediatr Hematol Oncol 35 257-267
- [17] Robison LL(2014)Medulloblastoma-translating discoveries from the bench to the bedside Nat Rev Clin Oncol 11 714-722
- [18] Packer RJ(2008)Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function Pediatr Blood Cancer 51 110-117
- [19] Packer RJ(2014)High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs Pediatr Blood Cancer 61 2285-2289
- [20] Vezina G(2019)Hypothalamic-pituitary function following childhood brain tumors: analysis of prospective annual endocrine screening Pediatr Blood Cancer 66 e27631-1294